Felicia Skipper, in Mccomb, MS - Speech-Language Pathologist

Felicia Skipper, is a Speech-language Pathologist based in Mccomb, Mississippi. Felicia Skipper is licensed to practice in Mississippi (license number S3150) and her current practice location is 206 Maryland Ave, Mccomb, Mississippi. She can be reached at her office (for appointments etc.) via phone at (601) 250-4815.

NPI number for Felicia Skipper is 1023223559 and her current mailing address is Po Box 791, Decatur, Mississippi. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023223559.

Contact Information

	Felicia Skipper,
	206 Maryland Ave, Mccomb, MS 39648-3926
	(601) 250-4815
	(601) 250-6859

Healthcare Provider's Profile

Full Name	Felicia Skipper
Gender	Female
Speciality	Speech-language Pathologist
Location	206 Maryland Ave, Mccomb, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1023223559
Provider Enumeration Date: 05/10/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Felicia Skipper such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023223559	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	S3150 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Felicia Skipper is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Felicia Skipper, Po Box 791, Decatur, MS 39327-0791 Ph: (601) 250-4815	Felicia Skipper, 206 Maryland Ave, Mccomb, MS 39648-3926 Ph: (601) 250-4815

News Archive

P. falciparum colonizes America via two separate introduction routes: Study

The malaria parasite, Plasmodium falciparum, originates from Africa, and is found on every continent. Over 200 million people are infected every year from Africa to Asia, as well as in America and the Middle East. How did it spread to the entire planet? It is not entirely clear how it conquered the New World. Scientists from the UMR Migevec and their partners have recently shown in the journal PNAS that the pathogen was introduced by ship during the slave trade.

EU gives 32 million Euro for vaccines to stop tuberculosis

The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.

Lifestyle change decreases cholesterol levels, reduces cardiovascular disease risk

Cholesterol levels - the most common risk factor for heart attacks - have decreased in northern Sweden over the last 20 years. Since medical drugs only account for a third of the decrease, the reduced risk of cardiovascular disease is greatly thanks to a change in lifestyle.

Parental AUDs associated with increased risk of AUDs among offspring: Study

Researchers know that there is a strong link between parental alcohol use disorders and the risk for developing an AUD among their offspring. This study looked at the risk of AUDs in the offspring of a large population-based sample of Danish parents. Findings confirmed that parental AUDs were associated with an increased risk of AUDs among the offspring.

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Millennium Pharmaceuticals today announced, in collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC, the initiation of VISTA (Velcadeas Initial Standard Therapy in multiple myeloma: Assessment with melphalan and prednisone), a multicenter, international phase III clinical trial of Velcadein combination with melphalan and prednisone versus melphalan and prednisone in patients with newly diagnosed multiple myeloma (MM) who are not transplant candidates.

Speech-Language Pathologist in Mccomb, MS

Laura Kathryn Price, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1115 Parklane Dr Ste 308, Mccomb, MS 39648 Phone: 601-810-3705 Fax: 877-236-7977
Anna Jones Lambert, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Main St, Mccomb, MS 39648 Phone: 601-249-2515 Fax: 601-684-7395
Felicia Murrah, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 206 Maryland Ave, Mccomb, MS 39648 Phone: 601-250-4815 Fax: 601-250-6859
Terri Anne Clements, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 318 Kendall Ave, Mccomb, MS 39648 Phone: 601-600-2633 Fax: 601-385-1626
Kyla Bland, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 206 Maryland Ave, Mccomb, MS 39648 Phone: 601-847-7040
Sonja Thurman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 206 Maryland Ave, Mccomb, MS 39648 Phone: 601-250-4815 Fax: 601-250-6859

Felicia Skipper, - Speech-Language Pathologist in Mccomb, MS